Background: Adverse events (AEs) after discharge occur in 19–28% of hospitalized patients.(1) Understanding whether patient-reported and clinical factors from the electronic health record (EHR) can predict post-discharge AEs is increasingly important given the growing population of hospitalized adults with multiple chronic conditions (MCC) being discharged home. This AHRQ-funded study aimed to develop an interoperable prediction [...]

Background: Medical errors are the third leading cause of death in the United States yet physicians report minimal education on how to disclose errors and adverse events. To Err is Human shed light on the severity of errors. As a result, communication and resolution programs were developed over the past two decades to attempt to [...]

Case Presentation: We report the case of a 45-year-old female with stage IA triple-negative breast cancer treated with neoadjuvant chemotherapy and pembrolizumab who developed secondary adrenal insufficiency due to adrenocorticotropic hormone (ACTH) deficiency six months after stopping the immune checkpoint inhibitor. She presented with persistent nausea, vomiting, weight loss, and altered mental status. Laboratory results [...]

Case Presentation: A 70-year-old man treated with Nivolumab for metastatic melanoma, presented with mild nausea and vomiting for a few days. He denied a change in urine output or appearance of urine, flank pain, or difficulty urinating. Creatinine on admission was 8.9 mg/dl (baseline 0.8mg/dl). Urinalysis revealed mild proteinuria, 21-50 WBCs/hpf. Spot protein/creatinine ratio was [...]

Case Presentation: An 80-year-old male with a history of atrial fibrillation post-ablation on apixaban, COPD, hypertension, and Stage IIIC malignant melanoma post-immunotherapy with nivolumab complicated by non-resolving pneumonitis presented with worsening dyspnea and tachycardia. In the ED, he was found to have atrial flutter with rapid ventricular response (RVR), elevated high-sensitivity troponin, and brain natriuretic [...]